Cite
HARVARD Citation
Mahomed, S. et al. (2020). Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial. BMJ open. 10 (11), p. . [Online].